Aldabra 4 Liquidity Opportunity Vehicle ALOV Sale Of Stock Consideration Received On Transaction

Sale Of Stock Consideration Received On Transaction at other companies

Camping World HoldingsCWH

$0-100%

Aclaris TherapeuticsACRS

$57.88M—

SouthStateSSB

$1.4M+1,400%

Revolution Medicines, Inc.RVMD

$12.21M+1,270%

AccentureACN

$452.12M-11.3%

Talkspace, Inc.TALK

$372K—

Operating income-$658.5K—

Net income$1.2M—

EPS (diluted)$0.04—

Cash & equivalents$1.1M—

Total equity-$11.7M—

Total assets$303.2M—

Operating cash flow-$710.6K—

Market cap$372.94M+1.2%

Current ratio12.8×—

Reported directly by Aldabra 4 Liquidity Opportunity Vehicle in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockConsiderationReceivedOnTransaction.

The official record: Aldabra 4 Liquidity Opportunity Vehicle ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Aldabra 4 Liquidity Opportunity Vehicle 's sale of stock consideration received on transaction?: Aldabra 4 Liquidity Opportunity Vehicle (ALOV) reported sale of stock consideration received on transaction of $294.91M in Q1 2026.